Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes
- Status
- COMPLETED
- Phase
- N/A
Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy
- Status
- COMPLETED
- Phase
- NA
Translating Research Into Practice: Patient Navigation for Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia
- Status
- TERMINATED
- Phase
- NA
A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening
- Status
- COMPLETED
- Phase
- NA
Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Status
- COMPLETED
- Phase
- PHASE1
Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
- Status
- COMPLETED
- Phase
- PHASE2
Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
- Status
- COMPLETED
- Phase
- NA
Evaluation of a mHealth Intervention to Increase Adherence to Triage of Self-collected HPV+ Women (ATICA Project)
- Status
- COMPLETED
- Phase
- NA
Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Improved Therapy Response Assessment in Metastatic Brain Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
MCS110 With BRAF/MEK Inhibition in Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds
- Status
- COMPLETED
- Phase
- N/A
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cancer Health Assessments Reaching Many
- Status
- COMPLETED
- Phase
- NA
Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA